Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomised, Open-label Phase III-IV Study to Evaluate the Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With Methicillin-susceptible Staphylococcus Aureus Bacteraemia: SAFO Trial

NCT03959345 is registered in ClinicalTrials.gov with Miquel Pujol as lead sponsor.

NCT NCT03959345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03959345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomised, Open-label Phase III-IV Study to Evaluate the Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With Methicillin-susceptible Staphylococcus Aureus Bacteraemia: SAFO Trial
Lead sponsor
Miquel Pujol
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2019
Completion date
February 24, 2022
Enrollment
215 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin susceptible staphylococcus aureus septicemia